Cargando…
The Effect of Hospice on End-of-Life Costs for Terminal Medicare Patients With HIV
One-quarter of annual Medicare expenses in the traditional program (non-Medicare Advantage) are expended for 5% of Medicare enrollees, with much of this expenditure occurring in the last year of life. Hospice use may reduce end-of-life costs. However, evidence has been inconclusive due to sample sel...
Autores principales: | Leibowitz, Arleen A., Tan, Diane, Gildner, Jennifer L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605034/ https://www.ncbi.nlm.nih.gov/pubmed/33118403 http://dx.doi.org/10.1177/0046958020969381 |
Ejemplares similares
-
Sexually Transmitted Infection Testing of HIV-Positive Medicare and Medicaid Enrollees Falls Short of Guidelines
por: Landovitz, Raphael J., et al.
Publicado: (2018) -
The cost of comorbidities in treatment for HIV/AIDS in California
por: Zingmond, David S., et al.
Publicado: (2017) -
WHO GETS HOSPICE VISITS AT THE END OF LIFE: A LOOK AT MEDICARE'S HOSPICE SERVICE INTENSITY ADD-ON POLICY
por: Plotzke, Michael, et al.
Publicado: (2022) -
Medicare Cost at End of Life
por: Duncan, Ian, et al.
Publicado: (2019) -
Racial and Ethnic Differences in Hospice Use and Hospitalizations at End-of-Life Among Medicare Beneficiaries With Dementia
por: Lin, Pei-Jung, et al.
Publicado: (2022)